Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Sharon Barbari
Age : 67
Public asset : 20,066 USD
Linked companies : VYNE Therapeutics Inc. - Agile Therapeutics, Inc.
Summary 
Sharon Barbari is on the board of Agile Therapeutics, Inc. and VYNE Therapeutics, Inc.

In the past she held the position of Chief Financial Officer at Gilead Sciences, Inc., Chief Financial Officer, Secretary & Executive VP at Cytokinetics, Inc., CFO, Senior VP-Finance & Administration at InterMune, Inc. and Vice President-Strategic Planning at Foote, Cone & Belding Healthcare.

Sharon Barbari received an undergraduate degree from San Jose State University.


Current positions of Sharon Barbari 
NameTitle Since
VYNE Therapeutics Inc.
(Pharmaceuticals)
Independent Director 2020
Agile Therapeutics, Inc.
(Biotechnology & Medical Research)
Independent Director 2020


Holdings of Sharon Barbari 
NameEquities%Valuation
Sonoma Pharmaceuticals, Inc. (SNOA)
(Pharmaceuticals)
4,8240.16%13,411 USD
VYNE Therapeutics Inc. (VYNE)
(Pharmaceuticals)
18,7500.032%5,869 USD
Agile Therapeutics, Inc. (AGRX)
(Biotechnology & Medical Research)
1,9520.0050%787 USD


Sharon Barbari: Personal Network 
Most Read News 
09/28Buffett's Berkshire Hathaway buys 5.99 million more Occidental shares
RE
09/26Unilever's soap opera: M&A, Nelson Peltz, CEO to retire
RE
10/04Musk says Twitter deal is 'accelerant' to creating 'everything app'
RE
09/26Twitter to interview Elon Musk, known for combative testimony
RE
09/21Trump ally Barrack's trial on foreign agent charges moves to opening statements
RE
09/28Elon Musk seeks to narrow SEC consent decree, end pre-approval of tweets
RE
09/29The long, winding road to Volkswagen's Porsche IPO
RE
09/21Bloomberg to spend $85 million against U.S. plastic, petrochem buildout
RE
09/21Samsung Elec's Lee says SoftBank's Son expected to visit Seoul -media
RE
09/30Elon Musk set to showcase Tesla's humanoid robot after delay
RE
More news


© 2022 People and Ownership :   
Sharon Barbari : Connections